These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7040211)

  • 1. [Five years experience with an influenza subunit vaccine (author's transl)].
    Majer M; Kindt H; Mettier B
    Immun Infekt; 1981 Nov; 9(6):232-8. PubMed ID: 7040211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Field trial of influenza virus hemagglutinin vaccine (author's transl)].
    Kimura Y
    Fukuoka Igaku Zasshi; 1975 May; 66(5):321-42. PubMed ID: 1236825
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative anti-influenza vaccination of some groups of the population with vaccines differing in virus purification level.
    Brydak L; Gall W; Semkow R
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):201-6. PubMed ID: 3447535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza I. Hemagglutinationinhibiting antibodies (author's transl)].
    Kuwert EK; Werner J; Scheiermann N; Pledt T
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):155-74. PubMed ID: 506543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
    Baldo V; Baldovin T; Floreani A; Carraro AM; Trivello R;
    Vaccine; 2007 May; 25(20):3955-61. PubMed ID: 17383057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Live influenza vaccines (author's transl)].
    Gerth HJ
    MMW Munch Med Wochenschr; 1977 Jun; 119(24):821-4. PubMed ID: 407467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.
    Dewe W; Benoit A; Legrand C
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):403-11. PubMed ID: 23927668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with Czechoslovak subunit anti-influenza vaccine (author's transl)].
    Závadová H; Vonka V; Stárek M; Domorázková E; Bruj J; Skocil V
    Cas Lek Cesk; 1975 Nov; 114(47):1462-6. PubMed ID: 1203931
    [No Abstract]   [Full Text] [Related]  

  • 9. [Field trial with a new type of influenza subunit vaccine (author's transl)].
    Kunz C; Hofmann H
    Wien Klin Wochenschr; 1976 Aug; 88(15):504-8. PubMed ID: 997532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
    Sindoni D; La Fauci V; Squeri R; Cannavò G; Bacilieri S; Panatto D; Gasparini R; Amicizia D
    J Prev Med Hyg; 2009 Jun; 50(2):121-6. PubMed ID: 20099444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with the clinical development of influenza vaccines for potential pandemics.
    Wood JM; Nicholson KG; Stephenson I; Zambon M; Newman RW; Major DL; Podda A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):197-201. PubMed ID: 12458360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.
    Del Giudice G; Fragapane E; Della Cioppa G; Rappuoli R
    Expert Opin Biol Ther; 2013 Jan; 13(1):121-35. PubMed ID: 23189937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunisation against influenza with a new subunit vaccine tested on children at risk (author's transl)].
    Luthardt T; Lutz O; Kindt H
    Dtsch Med Wochenschr; 1979 Jan; 104(2):56-60. PubMed ID: 759142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine 2011-2012.
    Med Lett Drugs Ther; 2011 Oct; 53(1375):81-3. PubMed ID: 21996921
    [No Abstract]   [Full Text] [Related]  

  • 17. Live attenuated influenza virus vaccine trial in children.
    Hall CB; Douglas G; Fralonardo SA
    Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.
    El Sahly H
    Expert Rev Vaccines; 2010 Oct; 9(10):1135-41. PubMed ID: 20923265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza and influenza vaccination.
    Goodman RA; Hinman AR; Nolan TF; Brandling-Bennett AD
    Am Fam Physician; 1980 Jan; 21(1):101-5. PubMed ID: 7350730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.